Francesca Fanelli
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The clinical impact of conventional therapies for adults and adolescents suffering from eosinophilic esophagitis, a type 2 inflammatory chronic disease, and their economic consequences in Italy: Systematic literature review and meta-analysis.
Journal: The journal of allergy and clinical immunology. Global
Published: July 18, 2024
A cost-of-illness study of eosinophilic esophagitis in Italy: assessing direct and indirect costs.
Journal: Frontiers in gastroenterology (Lausanne, Switzerland)
Published: April 08, 2024
Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.
Journal: The World Allergy Organization journal
Published: February 01, 2024
Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy.
Journal: Journal of personalized medicine
Published: May 03, 2022
Atopic dermatitis in schoolchildren and adolescents: a critical review of Italian epidemiological data and systemic treatments.
Journal: Italian journal of dermatology and venereology
Published: October 19, 2020
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.
Journal: Clinical and molecular allergy : CMA
Published: July 16, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT study.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 25, 2020
Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study.
Journal: Journal of diabetes research
Published: April 11, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026